Liverpool Health Genomics
Liverpool has considerable strength in basic and clinical research, underpinned by its existing Centres/hubs and world-class facilities and hospitals.
The Liverpool Health Genomics Laboratory (LHGL) aims to bridge the gap between basic research and clinical care through the characterisation and development of tools and biomarkers to improve health outcomes of patients living in the North West.
LHGL is enabled via a close working partnerships between:
- Liverpool Health Partners (LHP), an Academic Health Science Centre comprising a strategic partnership of 10 primary and secondary care NHS Organisations with UoL and Liverpool School of Tropical Medicine (LSTM), working together to deliver excellence in research, education and service delivery across Cheshire and Merseyside.
- The North West Coast Academic Health Science Network (NWC AHSN).
- The only academic Medicines and Healthcare Products Regulatory Agency (MHRA)-accredited Clinical Research Facility (CRF) in England and Wales in the Royal Liverpool University Hospital (RLBUHT) and NIHR Paediatric CRF at Alder Hey University Hospital.
- The genomics expertise residing in the CGR.
- The knowledge of pharmacology and drug safety science residing in the Wolfson Centre for Personalised Medicine.
- The NHS molecular diagnostics facilities located in Pathology in “Liverpool Clinical Laboratories” and at Liverpool Women’s Hospital NHS Foundation Trust.
Delivering Personalised Medicine
The facility is tasked with delivering translation of genetic research and personalised medicine initiatives to the patient population in the Liverpool area, taking potential markers for patients with, or at risk of, inflammatory and infectious diseases, rare and inherited disorders, sporadic genetic disorders, acquired disorders (e.g. cancer) and stratified medicine to deliver high-quality and comprehensive diagnostic genomic tests.
For further details, please contact LHGL.email@example.com.